244 related articles for article (PubMed ID: 33959972)
1. Intrinsic radiomic expression patterns after 20 Gy demonstrate early metabolic response of oropharyngeal cancers.
Lafata KJ; Chang Y; Wang C; Mowery YM; Vergalasova I; Niedzwiecki D; Yoo DS; Liu JG; Brizel DM; Yin FF
Med Phys; 2021 Jul; 48(7):3767-3777. PubMed ID: 33959972
[TBL] [Abstract][Full Text] [Related]
2. Early
Mowery YM; Vergalasova I; Rushing CN; Choudhury KR; Niedzwiecki D; Wu Q; Yoo DS; Das S; Wong TZ; Brizel DM
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):969-976. PubMed ID: 32800802
[TBL] [Abstract][Full Text] [Related]
3. External validation of an
Mori M; Deantoni C; Olivieri M; Spezi E; Chiara A; Baroni S; Picchio M; Del Vecchio A; Di Muzio NG; Fiorino C; Dell'Oca I
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1329-1336. PubMed ID: 36604325
[TBL] [Abstract][Full Text] [Related]
4. Radiomics on spatial-temporal manifolds via Fokker-Planck dynamics.
Stevens JB; Riley BA; Je J; Gao Y; Wang C; Mowery YM; Brizel DM; Yin FF; Liu JG; Lafata KJ
Med Phys; 2024 May; 51(5):3334-3347. PubMed ID: 38190505
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive values of baseline and mid-treatment FDG-PET in oropharyngeal carcinoma treated with primary definitive (chemo)radiation and impact of HPV status: Review of current literature and emerging roles.
Lin P; Holloway L; Min M; Lee M; Fowler A
Radiother Oncol; 2023 Jul; 184():109686. PubMed ID: 37142128
[TBL] [Abstract][Full Text] [Related]
6.
Li P; Wang X; Xu C; Liu C; Zheng C; Fulham MJ; Feng D; Wang L; Song S; Huang G
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1116-1126. PubMed ID: 31982990
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Value of Baseline 18F-FDG PET/CT in Human Papillomavirus-Positive Versus Human Papillomavirus-Negative Patients With Oropharyngeal Cancer.
Gouw ZAR; La Fontaine MD; van Kranen S; van de Kamer JB; Vogel WV; van Werkhoven E; Sonke JJ; Al-Mamgani A
Clin Nucl Med; 2019 May; 44(5):e323-e328. PubMed ID: 30889002
[TBL] [Abstract][Full Text] [Related]
8. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
[TBL] [Abstract][Full Text] [Related]
9. Investigation of radiomic signatures for local recurrence using primary tumor texture analysis in oropharyngeal head and neck cancer patients.
M. D. Anderson Cancer Center Head and Neck Quantitative Imaging Working Group
Sci Rep; 2018 Jan; 8(1):1524. PubMed ID: 29367653
[TBL] [Abstract][Full Text] [Related]
10. Radiomic Biomarkers to Refine Risk Models for Distant Metastasis in HPV-related Oropharyngeal Carcinoma.
Kwan JYY; Su J; Huang SH; Ghoraie LS; Xu W; Chan B; Yip KW; Giuliani M; Bayley A; Kim J; Hope AJ; Ringash J; Cho J; McNiven A; Hansen A; Goldstein D; de Almeida JR; Aerts HJ; Waldron JN; Haibe-Kains B; O'Sullivan B; Bratman SV; Liu FF
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1107-1116. PubMed ID: 29506884
[TBL] [Abstract][Full Text] [Related]
11. A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers.
Niyoteka S; Seban RD; Rouhi R; Scarsbrook A; Genestie C; Classe M; Carré A; Sun R; La Greca Saint-Esteven A; Chargari C; McKenna J; McDermott G; Malinen E; Tanadini-Lang S; Guckenberger M; Guren MG; Lemanski C; Deutsch E; Robert C
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4010-4023. PubMed ID: 37632562
[TBL] [Abstract][Full Text] [Related]
12. Mid-treatment Fluorodeoxyglucose Positron Emission Tomography in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma Treated with Primary Radiotherapy: Nodal Metabolic Response Rate can Predict Treatment Outcomes.
Lin P; Min M; Lai K; Lee M; Holloway L; Xuan W; Bray V; Fowler A; Lee CS; Yong J
Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):e586-e598. PubMed ID: 34373179
[TBL] [Abstract][Full Text] [Related]
13. Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer.
Gouw ZAR; La Fontaine MD; Vogel WV; van de Kamer JB; Sonke JJ; Al-Mamgani A
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):960-968. PubMed ID: 32361007
[TBL] [Abstract][Full Text] [Related]
14. Intratumor Heterogeneity Assessed by
Lue KH; Wu YF; Liu SH; Hsieh TC; Chuang KS; Lin HH; Chen YH
Acad Radiol; 2020 Aug; 27(8):e183-e192. PubMed ID: 31761665
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Overall Survival and Progression-Free Survival by the
Zhou Y; Ma XL; Pu LT; Zhou RF; Ou XJ; Tian R
Contrast Media Mol Imaging; 2019; 2019():5963607. PubMed ID: 31777473
[No Abstract] [Full Text] [Related]
16. Improved Prognosis of Treatment Failure in Cervical Cancer with Nontumor PET/CT Radiomics.
Yusufaly TI; Zou J; Nelson TJ; Williamson CW; Simon A; Singhal M; Liu H; Wong H; Saenz CC; Mayadev J; McHale MT; Yashar CM; Eskander R; Sharabi A; Hoh CK; Obrzut S; Mell LK
J Nucl Med; 2022 Jul; 63(7):1087-1093. PubMed ID: 34711618
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT improves detection of residual disease and reduces the need for examination under anaesthesia in oropharyngeal cancer patients treated with (chemo-)radiation.
de Ridder M; Gouw ZAR; Navran A; Hamming-Vrieze O; Jasperse B; van den Brekel MWM; Vogel WV; Al-Mamgani A
Eur Arch Otorhinolaryngol; 2019 May; 276(5):1447-1455. PubMed ID: 30758660
[TBL] [Abstract][Full Text] [Related]
18. Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
Liu HY; Milne R; Lock G; Panizza BJ; Bernard A; Foote M; McGrath M; Brown E; Gandhi M; Porceddu SV
Oral Oncol; 2019 Jan; 88():153-159. PubMed ID: 30616786
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment
Dissaux G; Visvikis D; Da-Ano R; Pradier O; Chajon E; Barillot I; Duvergé L; Masson I; Abgral R; Santiago Ribeiro MJ; Devillers A; Pallardy A; Fleury V; Mahé MA; De Crevoisier R; Hatt M; Schick U
J Nucl Med; 2020 Jun; 61(6):814-820. PubMed ID: 31732678
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma.
Alluri KC; Tahari AK; Wahl RL; Koch W; Chung CH; Subramaniam RM
AJR Am J Roentgenol; 2014 Oct; 203(4):897-903. PubMed ID: 25247958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
